TITLE

New Legislations on Generics and Biosimilars Brewing in Congress

AUTHOR(S)
Buffery, Dalia
PUB. DATE
April 2009
SOURCE
American Health & Drug Benefits;Apr/May2009, Vol. 2 Issue 3, p120
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reports on various bills being introduced in the 111th Congress, which proposes new legislations on generic drugs and biosimilars in the U.S. The H.R. 1706 bill, Protecting Access to Generic Drugs Act, introduced by Representative Bobby Rush, proposes to prohibit brand name drug companies from compensating generic drug companies to delay the entry of generics into the market. The H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act, reintroduced by Representative Henry Waxman, aims to provide the licensing of biosimilar and biogeneric biological products. Also, the H.R. 1548, Pathway for Biosimilars Act, reintroduced by Representative Anna Eshoo, weights the needs of patients and stakeholder companies.
ACCESSION #
39342897

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics